Drug Database
IN

insulin

✓ Approved

MJ Biotech · INSR · 重组蛋白

什么是 insulin?

insulin 是一种重组蛋白,由MJ Biotech研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

公司MJ Biotech
药物类别重组蛋白
分子靶点INSR
给药途径Injectable (Others)
状态Approved

作用机制

分子靶点

insulin 作用于 1 个分子靶点:

INSRinsulin receptor (CD220, HHF5)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

insulin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
InvestigationsGlucose tolerance test abnormal✓ Approved

相关研究文献

PubMedBMC microbiology2026-11-19

Secretory expression of mature recombinant elafin in Pichia pastoris and assessment of its in vitro antibacterial and antifungal effects.

Mokhtari Somayeh S, Lohrasbi-Nejad Azadeh A, Torkzadeh-Mahani Masoud M, Zolala Jafar J

Elafin is a small human host-defense peptide derived from trappin-2/pre-elafin, known for its antiprotease and anti-inflammatory functions. However, direct comparative evidence on the antimicrobial activity of mature recombinant elafin, particularly against fungal organisms, remains limited. This study aimed to produce secreted mature recombinant elafin in Pichia pastoris X-33 and comparatively assess its antimicrobial activity in vitro against Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 15,442, Staphylococcus aureus ATCC 29,737, and Candida albicans ATCC 10,231 using agar well diffusion, viable-count assays, broth microdilution, and minimum bactericidal/minimum fungicidal concentration (MBC/MFC) determination. The elafin insert was cloned into pPICZαA, and positive P. pastoris transformants were confirmed by colony PCR. Elafin was secreted into the culture medium, and the 66 h post-induction supernatant was selected for purification based on SDS-PAGE detection of a low-molecular-weight band in the expected size range. Purification resulted in a low-molecular-weight His-tagged recombinant product with migration consistent with the expected size of the designed elafin construct. In agar well diffusion assays, recombinant elafin produced inhibition zones of 32, 28, 25, and 22 mm for E. coli, P. aeruginosa, C. albicans, and S. aureus, respectively. Viable-count assays showed concentration- and time-dependent but modest reductions in recoverable cells, with all reductions remaining below 1 log₁₀ and the greatest effect observed at 62 µg/mL after 6 h. The minimum inhibitory concentration (MIC) values were 31 µg/mL for E. coli, P. aeruginosa, and C. albicans, and 62 µg/mL for S. aureus. The MBC values were 62 µg/mL for E. coli and P. aeruginosa, 124 µg/mL for S. aureus, and the MFC for C. albicans was 62 µg/mL. This study demonstrates the secretory expression and purification of a low-molecular-weight His-tagged recombinant product consistent with the designed mature elafin construct in P. pastoris. The purified peptide exhibited measurable in vitro inhibitory activity under defined assay conditions, supporting further evaluation of recombinant elafin in broader microbial and physiological models.

PMID 43052731
阅读全文 →
PubMedInsect science2026-11-19

The miR-11-3p/SNF axis modulates diet-responsive plasticity in larval molt number in Bombyx mori.

Sun Xiaoning X, Jiang Yanhong Y, Zhang Yi Y, Dai Taiming T et al.

Developmental plasticity enables insects to modify their developmental trajectories in response to environmental fluctuations. Here, we investigated diet-responsive plasticity in larval molt number, or moltinism, using the trimolter (3M) mutant SMJ (Short-instar Millet-yellow Jiangsu) of Bombyx mori. Stage-restricted feeding with old mulberry leaves increased the tetramolter (4M) proportion in SMJ and identified the second larval instar as a major period of dietary sensitivity. Transcriptomic and endocrine analyses revealed differences in cuticle formation and hormone-related processes in SMJ relative to its 4M parent MJ (Millet-yellow Jiangsu). Stage-matched endocrine profiling further showed that key events in the prothoracicotropic hormone-20-hydroxyecdysone axis and juvenile hormone-related processes occurred later in SMJ than in MJ. In SMJ, sustained hormonal perturbation during the second and third larval instars increased the 4M proportion, supporting a link between endocrine timing and moltinism plasticity. Using a robust model of calcium carbonate-induced moltinism shift, midgut small RNA sequencing identified miR-11-3p as a candidate regulator of diet-responsive plasticity in moltinism. Treatment with a miR-11-3p mimic markedly increased the 4M proportion in SMJ, whereas miR-11 knockout increased the 3M proportion in the 4M DaZao background under inductive conditions. Target prediction followed by expression and functional screening prioritized SNF (encoding U1 small nuclear ribonucleoprotein A), whose direct targeting by miR-11-3p was validated by dual-luciferase reporter assays; SNF knockdown phenocopied miR-11-3p mimic treatment by increasing the 4M proportion. Collectively, these findings identify the miR-11-3p/SNF axis as a post-transcriptional regulator that links dietary cues to plasticity in larval molt number.

PMID 43053477
阅读全文 →
PubMedDiabetes, obesity & metabolism2026-11-19

Insulin Secretion Modelling to Characterize Post-Bariatric Hypoglycaemia After Roux-en-Y Gastric Bypass.

Mohammadi-Asl E E, El Fathi A A, Pei L L, Saeed H H et al.

Roux-en-Y Gastric Bypass (RYGB) is an effective treatment for obesity and Type 2 diabetes. Some individuals develop postprandial hypoglycaemia, termed post-bariatric hypoglycaemia (PBH). PBH is associated with marked postprandial increases in incretin and insulin levels. This study investigates how insulin secretion differs between post-RYGB patients with and without hypoglycaemia by identifying key secretion parameters. Insulin secretion was modelled using plasma glucose, insulin and C-peptide concentration data obtained from mixed meal tolerance test in three cohorts: healthy individuals without a history of upper gastrointestinal surgery (controls, n = 11), post-RYGB individuals without hypoglycaemia (RYGB-non-hypo, n = 18) and post-RYGB individuals with hypoglycaemia (RYGB-PBH, n = 20). Meal-driven insulin secretion differed across groups (p = 0.008) and was significantly higher in RYGB-PBH than controls (0.23 vs. 0.14 pmol/mg, p = 0.006), but not in RYGB-non-hypo (0.22, p = 0.071). Glucose-driven insulin secretion decreased in RYGB-non-hypo (0.04 vs. 0.07 pmol/kg/min per mg/dL, p = 0.005) but did not differ from controls in RYGB-PBH (0.08, p = 0.948), differing significantly between the two post-RYGB groups (p < 0.001). Meal absorption was significantly faster in both post-RYGB groups (9.08 and 8.44 vs. 11.48 min, both p < 0.001). Models fit plasma insulin and C-peptide well (mean joint nRMSE: 0.60-0.92 across groups). Parameters were estimated with good precision (CV < 100%). Insulin secretion dynamics differ between post-RYGB patients with and without hypoglycaemia. Both groups showed faster meal absorption and a shift towards higher meal-driven secretion, significant only in RYGB-PBH, but only those without hypoglycaemia showed a reduction in glucose-driven secretion. This PBH model can support in silico development of glucagon-based interventions.

PMID 43053530
阅读全文 →
PubMedNPJ vaccines2026-11-19

Influenza neuraminidase as adjuvanted protein or mRNA vaccine protects mice against influenza A and B virus challenge.

Portela Catani João Paulo JP, Smet Anouk A, Ysenbaert Tine T, Amelinck Laura L et al.

Neuraminidase (NA) is an underutilized influenza vaccine antigen despite its recognized contribution to protective immunity. Here, we compared the immunogenicity and protective potential of multiple NA antigens delivered as an adjuvanted recombinant tetrameric protein or as mRNA-LNP encoding full-length NA in naïve mice. Both vaccine types induced robust neuraminidase-inhibiting (NAI) antibody responses and conferred protection to mice challenged with antigenically homologous influenza A or B viruses. However, only immunization with NA-encoding mRNA-LNP protected against challenge with a heterologous HxN2 virus, whereas immunization with recombinant NA was associated with earlier onset of weight loss following heterologous HxN2 virus challenge. Passive transfer of immune serum revealed that protection induced by mRNA immunization can be transferred by serum, and that early onset of weight loss is not induced by recombinant NA-derived sera; on the contrary, partial protection is achieved. Finally, NAI assays against a panel of antigenically distinct HxN2 viruses showed similar breadth of inhibition.

PMID 43052397
阅读全文 →
PubMedBMC biotechnology2026-11-19

Enhanced extracellular invertase production in Bacillus subtilis by boosting synthesis and secretion in a suitable chassis cell.

Yao Dongbang D, Chen Yuanyuan Y, Que Longwei L, Qi Jiaru J et al.

Soybeans are an important agricultural product, but they contain a significant amount of raffinose, which can cause flatulence when fermented by intestinal microorganisms. Invertase InvDz13 from Microbacterium trichothecenolyticum can effectively hydrolyze raffinose in soybean into the prebiotic melibiose, improving the nutritional value and economic benefits of soybean derivatives. However, its low yield limits industrial applications. This study produced InvDz13 in Bacillus subtilis, resulting in a recombinant enzyme with the natural enzyme's excellent properties. The extracellular InvDz13 production in B. subtilis was enhanced by boosting synthesis and secretion in a suitable chassis cell. Various extracellular protease-deficient chassis cells were constructed, and it was found that Vpr and WprA enhance the extracellular InvDz13 activity. The recombinant InvDz13 production was further enhanced by sequentially engineering the promoter, screening the signal peptide, and regulating key elements in the secretion pathway. The recombinant strain WBSS142I4PA, constructed using the promoter PspoVG-PspoVG142 and signal peptide SPYomL, co-expressing signal peptide peptidases SppA, exhibited a 10.02-fold increase in extracellular InvDz13 activity in shake flasks. Notably, the extracellular InvDz13 activity of WBSS142I4PA in a 3-L fermenter reached 568.86 U/mL. To our knowledge, this is the highest recombinant expression level of an exogenous invertase in B. subtilis reported so far. This is the first study to express InvDz13 in B. subtilis and develop a novel multidimensional combinatorial strategy to enhance its extracellular production. This study provides a theoretical foundation for the large-scale application of InvDz13 in soybean processing and paves novel avenues for protein production in B. subtilis.

PMID 43052969
阅读全文 →
PubMedJournal of physiological anthropology2026-11-19

Seasonal and daily rhythms in healthy adults and individuals with obesity: associations with selected hormones and lifestyle factors.

Kanikowska Dominika D, Sato Maki M

Biological timing systems, including circadian and seasonal rhythms, play a key role in regulating human physiology. The central circadian "body clock," located in the suprachiasmatic nucleus, coordinates daily rhythms both centrally and via peripheral clocks in metabolic tissues. Seasonal rhythms, in turn, are shaped by environmental cues such as photoperiod and temperature and may influence mood, appetite, sleep, physical activity, hormonal secretion, and thermoregulation. Although seasonal responses are generally weaker in humans than in many other animals, evidence suggests that some physiological processes remain seasonally regulated. From a physiological anthropology perspective, these rhythms can be viewed as adaptive mechanisms that align human physiology and behavior with predictable environmental changes. These timing systems are increasingly recognized as important regulators of metabolic homeostasis. Disruption of circadian and seasonal rhythms may contribute to insulin resistance, altered energy expenditure, fat accumulation, and obesity-related dysfunction. Human studies suggest that biological timing is reflected in chronotype-related behaviors, endocrine responses, seasonal hormonal variation, and thermoregulatory adaptation. Obesity is a complex, multifactorial disease that cannot be explained solely by excessive energy intake and low physical activity. It develops through interactions between external factors, such as an unhealthy diet and a sedentary lifestyle, and internal factors, including genetic, metabolic, endocrine, and behavioral mechanisms. Therefore, obesity should be understood not only as a disorder of energy balance but also as a condition influenced by disrupted biological timing. This article builds on our 2015 review (Kanikowska et al., Int J Biometeorol 59:377-84, 2015) by synthesizing recent literature and emerging perspectives on the roles of circadian and seasonal rhythms in obesity.

PMID 43053229
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多insulin